$361 Million is the total value of SABBY MANAGEMENT, LLC's 71 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 61.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ISHARES TRcall | $21,504,000 | -9.1% | 1,298 | -17.0% | 5.96% | -53.2% | |
| Sell | IONIS PHARMACEUTICALS INCcall | $17,887,000 | -1.7% | 2,961 | -2.5% | 4.96% | -49.4% | |
| Sell | SPDR GOLD TRcall | $15,290,000 | -28.7% | 1,070 | -55.9% | 4.24% | -63.3% | |
| Sell | SPDR S&P BIOTECHput | $4,756,000 | +23.0% | 500 | -1.4% | 1.32% | -36.7% | |
| Sell | AMARIN CORP PLCput | $4,387,000 | +26.0% | 2,046 | -10.9% | 1.22% | -35.2% | |
| ODT | Sell | ODONATE THERAPEUTICS INC | $1,747,000 | -27.7% | 53,839 | -42.0% | 0.48% | -62.8% |
| Sell | OBALON THERAPEUTICS INC | $1,084,000 | -18.5% | 570,418 | -16.8% | 0.30% | -58.0% | |
| Sell | BRAINSTORM CELLput | $894,000 | -12.0% | 2,088 | -19.9% | 0.25% | -54.7% | |
| PAVMZ | Sell | PAVMED INC*w | $836,000 | -11.9% | 2,152,719 | -27.4% | 0.23% | -54.6% |
| Sell | MICROBOT MED INC | $773,000 | +74.9% | 76,000 | -8.8% | 0.21% | -10.1% | |
| ATNM | Sell | ACTINIUM PHARMACEUTICALS INC | $713,000 | -64.8% | 3,275,718 | -62.8% | 0.20% | -81.8% |
| Sell | AURINIA PHARMACEUTICALScall | $590,000 | -34.2% | 291 | -82.6% | 0.16% | -66.0% | |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $576,000 | +10.8% | 94,351 | -24.4% | 0.16% | -42.9% |
| AMRN | Sell | AMARIN CORP PLCadr | $575,000 | +22.3% | 26,810 | -13.5% | 0.16% | -37.2% |
| INNT | Sell | INNOVATE BIOPHARMACEUTICLS INC | $525,000 | -60.7% | 941,586 | -24.6% | 0.15% | -79.7% |
| PULM | Sell | PULMATRIX INC | $384,000 | -55.7% | 446,749 | -57.8% | 0.11% | -77.3% |
| XBIO | Sell | XENETIC BIOSCIENCES INC | $382,000 | -21.1% | 265,498 | -34.4% | 0.11% | -59.4% |
| SYN | Sell | SYNTHETIC BIOLOGICS INC | $348,000 | -8.2% | 687,304 | -17.7% | 0.10% | -52.9% |
| XBIOW | Sell | XENETIC BIOSCIENCES INC*w | $297,000 | +15.1% | 216,789 | -18.7% | 0.08% | -41.0% |
| NSPR | Sell | INSPIREMD INC | $270,000 | -33.8% | 250,000 | -20.3% | 0.08% | -65.9% |
| OGEN | Sell | ORAGENICS INC | $184,000 | -44.9% | 351,045 | -43.3% | 0.05% | -71.7% |
| GNPX | Sell | GENPREX INC | $142,000 | -69.3% | 443,441 | -23.2% | 0.04% | -84.3% |
| CLSN | Sell | CELSION CORP | $117,000 | -51.2% | 68,560 | -56.1% | 0.03% | -75.2% |
| SHIPZ | Sell | SEANERGY MARITIME HOLDINGS CORP*w | $100,000 | -27.5% | 907,999 | -1.0% | 0.03% | -62.2% |
| VBLT | Sell | VASCULAR BIOGENICS LTD | $96,000 | -40.7% | 80,295 | -32.9% | 0.03% | -69.0% |
| SHIP | Sell | SEANERGY MARITIME HOLDINGS CORP | $27,000 | -95.4% | 49,999 | -95.9% | 0.01% | -97.8% |
| Sell | ADAMIS PHARMACEUTICALS CORPput | $8,000 | 0.0% | 111 | -2.6% | 0.00% | -50.0% | |
| BNTCW | Exit | BENITEC BIOPHARMA LTD*w | $0 | – | -51,449 | -100.0% | -0.00% | – |
| Exit | TITAN PHARMACEUTICALS INCput | $0 | – | -106 | -100.0% | -0.00% | – | |
| ONTXW | Exit | ONCONOVA THERAPEUTICS INC*w | $0 | – | -631,812 | -100.0% | -0.01% | – |
| TTNP | Exit | TITAN PHARMACEUTICALS INC | $0 | – | -83,218 | -100.0% | -0.01% | – |
| Exit | ALTIMMUNE INC COMput | $0 | – | -134 | -100.0% | -0.01% | – | |
| Exit | CELSION CORPcall | $0 | – | -260 | -100.0% | -0.02% | – | |
| Exit | SESEN BIO INCput | $0 | – | -365 | -100.0% | -0.02% | – | |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -42,007 | -100.0% | -0.02% | – |
| TMDI | Exit | TITAN MEDICAL INC | $0 | – | -41,085 | -100.0% | -0.02% | – |
| VISL | Exit | VISLINK TECHNOLOGIES INC | $0 | – | -115,314 | -100.0% | -0.03% | – |
| EYEN | Exit | EYENOVIA INC | $0 | – | -17,900 | -100.0% | -0.04% | – |
| ADMP | Exit | ADAMIS PHARMACEUTICALS CORP | $0 | – | -183,359 | -100.0% | -0.07% | – |
| Exit | CEL SCI CORPcall | $0 | – | -187 | -100.0% | -0.09% | – | |
| ABILF | Exit | ABILITY INC | $0 | – | -312,642 | -100.0% | -0.10% | – |
| RKDA | Exit | ARCADIA BIOSCIENCES INC | $0 | – | -50,000 | -100.0% | -0.13% | – |
| CYTR | Exit | CYTRX CORP | $0 | – | -729,450 | -100.0% | -0.13% | – |
| OPTT | Exit | OCEAN PWR TECHNOLOGIES INC | $0 | – | -150,000 | -100.0% | -0.14% | – |
| Exit | INPIXON | $0 | – | -2,360,220 | -100.0% | -0.15% | – | |
| HEPA | Exit | HEPION PHARMACEUTICALS INC | $0 | – | -115,000 | -100.0% | -0.15% | – |
| NURO | Exit | NEUROMETRIX INC | $0 | – | -934,212 | -100.0% | -0.16% | – |
| Exit | KADMON HLDGS INCput | $0 | – | -114 | -100.0% | -0.17% | – | |
| CUR | Exit | NEURALSTEM INC | $0 | – | -204,823 | -100.0% | -0.18% | – |
| Exit | ORAMED PHARMACEUTICALS INCcall | $0 | – | -1,120 | -100.0% | -0.19% | – | |
| ALRN | Exit | AILERON THERAPEUTICS INC | $0 | – | -549,900 | -100.0% | -0.20% | – |
| AVCO | Exit | AVALON GLOBOCARE CORP | $0 | – | -197,119 | -100.0% | -0.20% | – |
| ADXS | Exit | ADVAXIS INC | $0 | – | -1,521,982 | -100.0% | -0.22% | – |
| VBIV | Exit | VBI VACCINES INC | $0 | – | -876,157 | -100.0% | -0.22% | – |
| Exit | GENOCEA BIOSCIENCES INCcall | $0 | – | -1,481 | -100.0% | -0.23% | – | |
| VXRT | Exit | VAXART INC | $0 | – | -1,197,710 | -100.0% | -0.23% | – |
| SEEL | Exit | SEELOS THERAPEUTICS INC | $0 | – | -491,237 | -100.0% | -0.24% | – |
| SOLO | Exit | ELECTRAMECCANICA VEHS CORP | $0 | – | -288,408 | -100.0% | -0.32% | – |
| ORMP | Exit | ORAMED PHARMACEUTICALS INC | $0 | – | -185,800 | -100.0% | -0.32% | – |
| CTXR | Exit | CITIUS PHARMACEUTICALS INC | $0 | – | -845,432 | -100.0% | -0.34% | – |
| Exit | CEL SCI CORPput | $0 | – | -855 | -100.0% | -0.41% | – | |
| BHVN | Exit | BIOHAVEN PHARMACEUTICAL HLDG CO LTD | $0 | – | -19,850 | -100.0% | -0.45% | – |
| BNTC | Exit | BENITEC BIOPHARMA LTDadr | $0 | – | -1,365,615 | -100.0% | -0.52% | – |
| Exit | CORMEDIX INCput | $0 | – | -1,936 | -100.0% | -0.67% | – | |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDG INC | $0 | – | -124,843 | -100.0% | -0.69% | – |
| CJJD | Exit | CHINA JO-JO DRUGSTORES INC | $0 | – | -1,325,299 | -100.0% | -0.86% | – |
| CRMD | Exit | CORMEDIX INC | $0 | – | -249,198 | -100.0% | -0.86% | – |
| Exit | BIOHAVEN PHARMACEUTICAL HLDG CO LTDput | $0 | – | -412 | -100.0% | -0.93% | – | |
| TEUM | Exit | PARETEUM CORP | $0 | – | -2,248,578 | -100.0% | -1.56% | – |
| Exit | ISHARES TRput | $0 | – | -1,578 | -100.0% | -12.87% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.